PharmaTher Files With FDA For Orphan Drug Designation In Use Of Ketamine For ALS
PharmaTher Holdings (CSE: PHRM) this morning announced that it has filed with the US FDA for orphan drug designation as
Read more
Ketamine
PharmaTher Receives FDA Approval For Ketamine Trial For Parkinson’s
PharmaTher Holdings (CSE: PHRM) has seen the US FDA approve the firms application for an investigational new drug. The approval
Read more
PharmaTher Acquires Exclusive Rights To Patented Ketamine Formulation
PharmaTher Inc (CSE: PHRM) has entered into an exclusive worldwide license agreement for the development and commercialization of a patented
Read more
Artificial Intelligence Meets Psychedelics – The Daily Dive feat Fabio Chianelli
Today on the Daily Dive, Fabio Chianelli, CEO of PharmaTher Inc (CSE: PHRM) sits down with our host Cassandra Leah
Read more
Harvest Moon: Reducing Suicidal Ideation With Ketamine Infusions
Suicidal ideation is an emergent condition that demands immediate attention. It has been shown that the time between decision and
Read more